Master the complexities of pancreatic surveillance at scale.

Pancreatic abnormalities require years of precise follow-up to catch malignancy early. Eon Pancreas identifies incidental findings and automates the multi-year surveillance schedule, ensuring no patient falls through the cracks.
Request a demo

Pancreatic cysts are the most common identifiable precursor to pancreatic cancer, yet most never receive follow-up.

Addressing a modifiable risk factor.

Not all cysts need immediate intervention, but they may require lifetime surveillance. Eon standardizes care workflows so low-risk cysts stay on the radar while high-risk patients are routed to HPB specialists for immediate intervention.

Moving the needle on mortality.

A multi-year surveillance schedule requires tight tracking and coordination. Eon listens to the EMR for updates in any pancreas-related imaging and automatically modifies the patient's care plan accordingly, ensuring every milestone for a pancreatic finding is met with the appropriate clinical action.

Modernize your surveillance approach to change the narrative on pancreatic cancer.

Identify patients across all radiology settings for efficient, risk-stratified routing.
Capture every patient
Embed your guidelines, workflows, and pathways for consistent care.
Standardize care
Easily manage surveillance and workflows across multiple sites.
Centralize for scale
Ensure patients get the right care at the right time – every time.
Drive adherence and
outcomes

Specialized pancreas AI for systemwide cyst surveillance.

Identify Patients
PRECISION IDENTIFICATION™

Clinical intelligence you can act on immediately

There’s data and there’s truth. While most AI extracts general findings, Eon’s disease-specific models deliver >99% precision across 50+ clinical markers, ensuring care teams can trust what they see and act with confidence.

Validate Data
SMART VALIDATION™

Turn AI from human supervision to trustworthy automation

Every clinical AI output requires human validation. Eon reduces the manual burden of this effort down to a fraction of the time, giving navigators hours back for patient care—not data review.

Determine Follow-up
INTELLIGENT CARE PLANS

Evidence-based follow-up recommendations, instantly delivered

Radiology reports aren’t roadmaps—nearly half of them omit a clear next step. When one is present, Eon incorporates it into the care plan. When it isn’t, Eon leverages validated findings to generate an evidence-based care plan that you can activate in one click.

Monitor Adherence
FOLLOW-UP LISTENER™

Dynamic follow-up that adapts to the unexpected

Most systems track what’s expected. Eon detects the unexpected—new imaging, evolving risk, stalled care—and automatically adapts the care plan to clinical circumstances, flagging the record for navigator action.

Drive Performance
EON INSIGHTS

Capture the insights that drive better care

Like incidental findings, critical data can be buried in reports or tracked in disparate ways across sites. Eon gives clinical, operational, and executive teams the visibility they need to measure program impact and support patient outcomes systemwide.

Early detection and stage shift for your patients and program.

“The software can accurately identify a malignancy in or around the pancreas, and more expeditiously move that patient into cancer care pathways.”

Russell C. Langan, MD, FACS, FSSO, Associate Chief Surgical Officer, System Integration and Quality & Director of Surgical Oncology, RWJBarnabas

37x

increase in patients
identified

Eon captures hidden risk that manual chart review simply cannot scale to catch.

77%

Return-to-care rate for
high-risk cyst patients

(≤30% national benchmark)

AI-driven follow-up and surveillance ensure patients don't fall through cracks as months turn into years.

55%

cancers caught at
non-metastatic stages

(higher than baselines)

Health systems can successfully shift from late-stage crises to operable interventions.

RWJBarnabas Health | August 2020 - October 2025

Get a custom value analysis for your pancreas population

In a population of 100,000 patients, hundreds of incidental pancreatic findings are hiding in the data. We’ll analyze your radiology report history to show the clinical volume you might be missing and how many patients could be brought into a safe surveillance program.

Request a consult

Dive deeper into pancreatic insights, innovation, and impact.

Increase early detection and stage shift with AI

Download now
Click here to read more

Why academic medical centers are uniquely positioned to close...

Read the blog
Click here to read more

5 reasons pancreatic cysts demand more than passive surveillance

Download now
Click here to read more

Six steps to a successful pancreatic surveillance program

Download now
Click here to read more